In the News
March 3, 2026
Press Release
Announcing the Call for Proposals for the 2026 Sir Lady Mireille and Sir Dennis Gillings Global Public Health Fellowship
New York, NY — March 3, 2026 — The Pasteur Foundation proudly announces the launch of the 2026 call for applications for the Lady Mireille & Sir Dennis Gillings Global Public Health Fellowship, a transformative two-year postdoctoral program at the Institut Pasteur in Paris.
Created through the visionary leadership of Lady Mireille Gillings, this Fellowship is designed to cultivate a new generation of scientific leaders capable of reshaping the future of global public health. At a time when the world faces increasingly complex health challenges — from emerging infectious diseases to climate-driven health threats — the need for scientists who can bridge discovery, leadership, and global impact has never been greater.
The Fellowship distinguishes itself by combining rigorous, world-class biomedical research with structured training in leadership, strategic management, and resource mobilization. Fellows are embedded in leading laboratories at Institut Pasteur while simultaneously developing the tools required to build institutions, mobilize capital, and translate breakthrough science into durable global solutions.
Applications open March 3, 2026, and are open exclusively to exceptional PhD graduates from the University of Cambridge, the University of North Carolina Gillings School of Global Public Health, and Concordia University who have completed their doctoral degrees within two years of the application deadline.
Yasmine Belkaid, President of Institut Pasteur, said: “The visionary leadership of Lady Mireille in establishing this fellowship represents a bold investment in the future architects of global health. Scientific discovery alone does not change the world — leadership does. This program reflects our conviction that tomorrow’s breakthroughs will be driven by scientists who are as fluent in vision and strategy as they are in the laboratory.”
Lady Mireille Gillings, PhD, Hon DSc, said: “Future leaders in public health must have skills across what I call the 3Ms: Money, Management and Medicine. The fellowships are designed to build business skills on top of scientific training, which is critical for the next generation of global scientists.”
Through this Fellowship, the Pasteur Foundation reinforces its commitment to transatlantic scientific excellence and to advancing a model of research leadership that is ambitious, interdisciplinary, and globally minded.
For full eligibility criteria and application details, please visit: https://pasteurfoundation.org/lady-mireille-gillings-fellowship/
Media Contact:
Pasteur Foundation info@pasteurfoundation.org, +1-646-389-2124
May 27, 2025
Update
Accelerating Vaccines, Advancing Global Health: Institut Pasteur Helps Launch European Vaccine Hub with Implications for the U.S. and Beyond 💉
The Pasteur Foundation is proud to share a major milestone in international scientific collaboration: the launch of the European Vaccine Hub (EVH)—an ambitious new initiative funded by the European Commission with €102 million and co-led by our longtime partner, the Institut Pasteur.
The EVH is more than a European success story. It represents a global model for pandemic preparedness and rapid vaccine development, with direct relevance for U.S. and global health security. Designed to cut vaccine development timelines to under four months following pathogen identification, the EVH will draw on the collective expertise of leading European institutions while establishing frameworks that can be adapted and scaled worldwide.
As a founding member, the Institut Pasteur brings world-class strength in vaccinology and immunology to this effort—expertise that continues to be supported by the Pasteur Foundation and our community of American donors and partners. The initiative is part of the broader Pasteur 2030 strategic vision, which includes the creation of a new Center for Vaccinology and Immunotherapy (CVI). This integrated research platform bridges fundamental science and clinical validation to deliver vaccine candidates at record speed.
In France, the Institut Pasteur will work closely with national partners such as INSERM, ANRS-MIE, CEA, and AP-HP, reinforcing a coordinated response to infectious disease threats. But the ripple effects of the EVH extend well beyond Europe. With scientific diplomacy and global equity at its core, the Hub represents an opportunity for transatlantic collaboration, knowledge exchange, and scalable vaccine technologies that can benefit populations across borders.
At the Pasteur Foundation, we see the EVH as a powerful reminder of why international cooperation matters—and why American investment in global science continues to be essential. Together, through partnerships like this, we move closer to a world prepared for the health crises of tomorrow.
April 28, 2025
Press Release
HIV: genetic characteristics associated with sustained HIV remission after stopping treatment
November 8, 2025